Clinical trial
Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious…
NCT00453804 · State University of New York - Upstate Medical University, Other · Completed
Key facts
| NCT number | NCT00453804 |
|---|---|
| Title | Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI) |
| Official title | Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI): A Pilot Study |
| Acronym | vivitrol |
| Lead sponsor | State University of New York - Upstate Medical University, Other |
| Collaborators | Cephalon Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorders, Schizophrenia, Schizoaffective Disorders, Alcohol Dependence |
| Intervention type | Drug |
| Interventions | injectable naltrexone, oral naltrexone |
| Enrollment | 15 |
| Start date | Jul 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Mar 29, 2007 |
| Last update posted | Mar 18, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: